Making Science Group's Days Sales Outstanding for the
six
months ended in Dec. 2025 was 65.16.
Making Science Group's Days Inventory for the
six
months ended in Dec. 2025 was 4.01.
Making Science Group's Days Payable for the
six
months ended in Dec. 2025 was 57.79.
Therefore, Making Science Group's Cash Conversion Cycle (CCC) for the
six
months ended in Dec. 2025 was 11.38.
Making Science Group (FRA:MS7) Cash Conversion Cycle Explanation
Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.
Be Aware
CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.
The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.
Making Science Group Cash Conversion Cycle Related Terms
Making Science Group Cash Conversion Cycle Historical Data
* Premium members only.
The historical data trend for Making Science Group's Cash Conversion Cycle can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:MS7 vs APP, OMC, TTD: Cash Conversion Cycle Comparison
For the Advertising Agencies subindustry, Making Science Group's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Making Science Group Cash Conversion Cycle vs Media - Diversified Industry
For the Media - Diversified industry and Communication Services sector, Making Science Group's Cash Conversion Cycle distribution charts can be found below:
* The bar in red indicates where Making Science Group's Cash Conversion Cycle falls into.
Making Science Group Cash Conversion Cycle Calculation
Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.
Cash Conversion Cycle is one of several measures of management effectiveness.
Making Science Group's Cash Conversion Cycle for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Making Science Group (FRA:MS7) has a Cash Conversion Cycle of 11.38 as of Dec. 2025. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on Making Science Group and its competitors.
Is Making Science Group's Cash Conversion Cycle too high?
Making Science Group's current Cash Conversion Cycle is 11.38. The Media - Diversified industry median Cash Conversion Cycle is 20.19. Making Science Group's value of 11.38 is 43.6% below this industry median. Overall, Making Science Group has a GF Score™ of 67/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Making Science Group's Cash Conversion Cycle compare to APP and OMC?
Making Science Group's Cash Conversion Cycle of 11.38 can be compared against companies in the Media - Diversified industry. The industry median Cash Conversion Cycle is 20.19. Making Science Group's value of 11.38 is 43.6% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Conversion Cycle for a Media - Diversified company?
The median Cash Conversion Cycle among Media - Diversified companies is 20.19, based on 1,012 companies in the industry. Companies in the top quartile (top 25%) have a Cash Conversion Cycle significantly above this median, while those in the bottom quartile fall well below. However, Cash Conversion Cycle should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Making Science Group's current Cash Conversion Cycle of 11.38 is 43.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Conversion Cycle mean?
A high Cash Conversion Cycle can signal that a stock is expensive relative to its fundamentals. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on Making Science Group and its competitors. For the Media - Diversified industry, the median Cash Conversion Cycle is 20.19 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Making Science Group's current Cash Conversion Cycle is 11.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Making Science Group stock overvalued right now?
Based on GuruFocus' analysis, Making Science Group (FRA:MS7) is currently considered Significantly Undervalued. The stock's GF Value™ is €11.68, compared to a current price of €6.75 — trading 42.2% below its estimated fair value. The current Cash Conversion Cycle is 11.38 and 43.6% below the Media - Diversified industry median of 20.19. Making Science Group's overall GF Score™ is 67/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Conversion Cycle calculated?
Cash Conversion Cycle is calculated from a company's financial statements. For Making Science Group (FRA:MS7), the current Cash Conversion Cycle is 11.38 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Making Science Group (FRA:MS7) Overvalued in 2026?
Based on GuruFocus' analysis, Making Science Group stock appears to be undervalued.
The current stock price of €6.75 is trading 42.2% below its estimated GF Value™ of €11.68.
GuruFocus considers Making Science Group to be Significantly Undervalued.
Key valuation signals for FRA:MS7:
Cash Conversion Cycle: 11.38
GF Value™: €11.68 vs. price of €6.75 (42.2% below fair value)
Industry Position: 43.6% below the Media - Diversified median
No single metric tells the full story. See the FRA:MS7 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Making Science Group SA is engaged in the business of technology and marketing solutions for the e-commerce and digital transformation business. The company provides solutions in the areas of digital marketing, data analytics, e-commerce, and cloud. The company carries out its professional activity in the United States, Spain, Italy, France, and other. The company obtains its income mainly from advertising and public relations services. The business segments are: Spain; International; and E-commerce and Product. The Spain and International segments, the business lines are Media and Digital Marketing, Cloud Solutions, Software & Cybersecurity, and proprietary Adtech technology. The E-commerce and Product segment focuses on the Marketplace and E-commerce business lines.
67GF Score
Get the complete analysis for FRA:MS7
Cash Conversion Cycle is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:MS7 has been successfully added to your 
